Sloan Foundation Awards $3 Million for Genome Sequencing Facility
Sloan Foundation Awards $3 Million for Genome Sequencing Facility
The New York Genome Center has announced a $3 million grant from the Alfred P. Sloan Foundation to help build the infrastructure needed to support a large-scale genome sequencing and bioinformatics facility for translational research.
The grant will enable NYGC to recruit and support core bioinformatics and sequencing professionals, part of a team that it expects to number three hundred and fifty people over the next several years. Over the next five years, NYGC aims to create more than five hundred science-related jobs and have a significant impact on the fields of science and technology.
Founded in 2010, NYGC works to build New York City's genomics and bioinformatics capacity, enabling it to compete globally, diversify its economy, and better support the development of new diagnostics and therapeutics that improve patient care. The organization combines the power of eleven top-tier academic institutions, including Cold Spring Harbor Laboratory, Weill Cornell Medical College, and Memorial Sloan-Kettering Cancer Center, together with leaders in technology and pharmaceuticals.
"We are very pleased that the Alfred P. Sloan Foundation recognizes the importance of investing in large-scale genomic sequencing, bioinformatics, data mining, and translational research," said NYGC founding executive director Nancy. J. Kelley. "NYGC's mission and operations align with the Sloan Foundation's commitment to support unique opportunities that will benefit the New York metro area in ways that advance the foundation's interests in science, technology, and economic performance."
| 
